Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18485271 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study
Condition: Asthma
Interventions: Drug: extra-fine hydrofluoroalkane beclometasone dipropionate;   Drug: Fluticasone propionate

Indicates status has not been verified in more than two years